Chinese Hong Kong boutique investment bank SIBO (SIBO.US) resubmits its US stock IPO application, aiming to raise up to $15 million.
On Wednesday, Spotify re-submitted its application for an initial public offering (IPO) to the U.S. Securities and Exchange Commission (SEC), with plans to raise up to $15 million.
The boutique investment bank and financial services provider Sibo Holding in Hong Kong, China, re-submitted their initial public offering (IPO) application to the U.S. Securities and Exchange Commission (SEC) on Wednesday, with plans to raise up to $15 million. The company originally filed an F-1 registration statement in August 2025, and set preliminary terms later that month. It is understood that Sibo withdrew their initial F-1 registration statement earlier on Wednesday.
It is understood that the boutique investment bank plans to raise $15 million by issuing 15.8 million shares at a price of $4 per share. With the proposed offering size, the company's valuation would reach $63 million.
Sibo operates through its subsidiary StormHarbour HK. Over the past three years, the company has raised over $900 million for clients in various transactions (including loans and equity sales). StormHarbour HK's revenue mainly comes from service fees and commissions, including commissions earned as introducing brokers.
StormHarbour HK divides its business into two core segments: Capital Markets (focused on private equity, private debt financing, and financial and financial advisory services) and Asset Management (providing services such as fund management, investment solutions, wealth management, and private banking account advisory).
Founded in 2009, the company based in Hong Kong, China, generated revenues of $5 million in the past 12 months ending on June 30, 2025. Sibo plans to list on the NASDAQ under the ticker symbol "SIBO". The company secretly submitted the listing application on March 25, 2025. R.F. Lafferty & Co. is the exclusive lead underwriter for this transaction.
Related Articles

On January 16, BEKE-W (02423) spent $3.5 million to repurchase 603,500 shares.

New stock news | Qinhao Pharmaceuticals submits application to Hong Kong Stock Exchange, mainly focusing on developing potential best-in-class targeted therapies in the field of oncology.
.png)
New Stock Update | Moganshan Home Delivery Form to Hong Kong Stock Exchange, serving as China's third largest green artificial board service provider.
On January 16, BEKE-W (02423) spent $3.5 million to repurchase 603,500 shares.

New stock news | Qinhao Pharmaceuticals submits application to Hong Kong Stock Exchange, mainly focusing on developing potential best-in-class targeted therapies in the field of oncology.

New Stock Update | Moganshan Home Delivery Form to Hong Kong Stock Exchange, serving as China's third largest green artificial board service provider.
.png)





